Infectious Diseases News and Research

RSS

Researchers study bacterial co-infections and antibiotic use in COVID-19 patients

Researchers estimated the frequency of bacterial co-infections among hospitalized coronavirus disease 2019 (COVID-19) patients and of antibiotic prescriptions in the initial COVID-19 period for appraising the usage of antibiotic stewardship criteria.

13 Jan 2023

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.

11 Jan 2023

Study describes a mechanism associated with the production of neuropathic pain

Neuropathic pain is a type of chronic pain caused by damage to the nervous system due mainly to metabolic diseases such as diabetes and arthritis, or to the side effects of some kinds of chemotherapy.

10 Jan 2023

Developing new tools to accelerate spatial genomics and drug discovery

We speak to Dr. George Emanuel from Vizgen about their new MERSCOPE Platform and how it is accelerating the field of drug discovery by combining both single-cell and spatial genomics.

From Vizgen 10 Jan 2023

What were the risks and patterns of childhood deaths before and during the COVID-19 pandemic?

A new study describes the pattern of childhood deaths over 2019-21, the first two years of the pandemic, hoping to help identify the risks associated with these events.

10 Jan 2023

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses

A new initiative to better understand respiratory viruses has been launched today (10 January 2023) by the Wellcome Sanger Institute.

10 Jan 2023

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine doses

In a recent correspondence published in The Lancet Infectious Diseases journal, researchers in Germany assessed the neutralization sensitivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB.1 lineage.

9 Jan 2023

Less than four in 100 men reach the end of the sperm donation process

Less than four in 100 men who apply to be sperm donors reach the end of the process and have samples frozen and released for treatments, according to a new study.

9 Jan 2023

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease.

6 Jan 2023

Hybrid immunity confers increased protection against omicron BA.5 for up to 8 months

Study in the population living in Portugal shows that immunity conferred by infection of people vaccinated against COVID-19 confers up to 8 months of protection against omicron BA.5.

6 Jan 2023

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

Trials into vaccines for cancer and wider diseases will accelerate after the government reached a historic agreement with a leading biopharmaceutical firm to bring revolutionary research to England.

5 Jan 2023

Specific air pollutants linked to non-viral asthma attacks among children in urban communities

Moderate levels of two outdoor air pollutants, ozone and fine particulate matter, are associated with non-viral asthma attacks in children and adolescents who live in low-income urban areas, a study funded by the National Institutes of Health has found.

5 Jan 2023

Oxford's Ebola vaccine candidate manufactured and shipped to Uganda in just 80 days

Oxford's Ebola vaccine candidate has been shipped to Uganda, just 80 days after WHO declared a Sudan ebolavirus outbreak, having been manufactured by its partner the Serum Institute of India and working in close partnership with WHO.

5 Jan 2023

Recently discovered protein holds potential for the development of new tests for infectious diseases

In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA, single-stranded DNA and double-stranded DNA.

4 Jan 2023

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.

4 Jan 2023

Analyzing electronic medical records to identify COVID-19 sequelae

In a recent study published in the journal Emerging Infectious Diseases, researchers analyzed and compared pre‒ and post‒COVID-19 diagnostic codes to identify symptoms that had higher encounter incidence in the post‒COVID-19 period as sequelae. COVID-19 sequelae and future emerging diseases can be generated and monitored using this method.

3 Jan 2023

Effects of hybrid immunity on humoral immune response following COVID mRNA vaccination in a cohort of essential and frontline workers

Researchers longitudinally evaluated humoral immune responses to the second and third doses of COVID-19 mRNA vaccines among individuals with and without prior history of SARS-CoV-2 infections.

3 Jan 2023

Study demonstrates the benefits of vaccination and boosting in reducing COVID-19 transmission

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by researchers at UC San Francisco that examined transmission between people living in the same cell.

2 Jan 2023

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Researchers compared coronavirus disease 2019 (COVID-19)-specific long-term consequences to other viral respiratory infections.

29 Dec 2022

Study reveals a previously unappreciated complexity of TRM cell biology in the gut

Recent pressure to maximize vaccine efficacy has stirred up many new discoveries within immunology, revealing numerous paradigms with untapped therapeutic potential.

28 Dec 2022

Infectious Diseases News and Research

Researchers study bacterial co-infections and antibiotic use in COVID-19 patients

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Study describes a mechanism associated with the production of neuropathic pain

Developing new tools to accelerate spatial genomics and drug discovery

What were the risks and patterns of childhood deaths before and during the COVID-19 pandemic?

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine doses

Less than four in 100 men reach the end of the sperm donation process

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

Hybrid immunity confers increased protection against omicron BA.5 for up to 8 months

Historic agreement to accelerate trials into vaccines for cancer and wider diseases

Specific air pollutants linked to non-viral asthma attacks among children in urban communities

Oxford's Ebola vaccine candidate manufactured and shipped to Uganda in just 80 days

Recently discovered protein holds potential for the development of new tests for infectious diseases

Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malaria

Analyzing electronic medical records to identify COVID-19 sequelae

Effects of hybrid immunity on humoral immune response following COVID mRNA vaccination in a cohort of essential and frontline workers

Study demonstrates the benefits of vaccination and boosting in reducing COVID-19 transmission

What are the long-term consequences following COVID-19 and other viral respiratory infections?

Study reveals a previously unappreciated complexity of TRM cell biology in the gut

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News